Evidence map›Paper›PMID 40073342›Full record

ArticlePloS one2025

Association of family history of cardiovascular disease with the prevalence of cardiometabolic risk factors in young adults in the United Arab Emirates: The UAE healthy future study.

Fatima Mezhal, Amar Ahmad, Abdishakur Abdulle, Andrea Leinberger-Jabari, Abdulla AlJunaibi, Abdulla Alnaeemi, Ayesha S Al Dhaheri, Eiman AlZaabi, Fatma Al-Maskari, Fatme AlAnouti and 13 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Fatima MezhalPublic Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.ORCID https://orcid.org/0000-0003-0722-7104
Amar AhmadPublic Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Abdishakur AbdullePublic Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Andrea Leinberger-JabariPublic Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Abdulla AlJunaibiDepartment of Pediatric Endocrinology, Danat Al Emarat Hosiptal, Abu Dhabi, United Arab Emirates.
Abdulla AlnaeemiDepartment of Cardiology, Zayed Military Hospital, Abu Dhabi, United Arab Emirates.
Ayesha S Al DhaheriDepartment of Nutrition and Health, College of Medicine and Health Sciences, UAE University, Al-Ain, United Arab Emirates.
Eiman AlZaabiDepartment of Pathology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
Fatma Al-MaskariInstitute of Public Health, College of Medicine and Health Sciences, UAE University, Al-Ain, United Arab Emirates.
Fatme AlAnoutiCollege of Natural and Health Sciences, Zayed University, Abu Dhabi, United Arab Emirates.ORCID https://orcid.org/0000-0002-1993-6656
Juma AlkaabiDepartment of Internal Medicine, College of Medicine and Health Sciences, UAE University, Al-Ain, United Arab Emirates.
Marina KazimAbu Dhabi Blood Bank Services, SEHA, Abu Dhabi, United Arab Emirates.
Mohammad Al-HouqaniDepartment of Medicine, College of Medicine and Health Sciences, UAE University, Al-Ain, United Arab Emirates.ORCID https://orcid.org/0000-0003-4481-3911
Mohammad Hag AliDepartment of Health Science, Higher Colleges of Technology, Abu Dhabi, United Arab Emirates.
Naima OumezianeAbu Dhabi Blood Bank Services, SEHA, Abu Dhabi, United Arab Emirates.
Omar El-ShahawyDepartment of Population Health, New York University School of Medicine, New York, New York, United States of America.
Scott ShermanDepartment of Population Health, New York University School of Medicine, New York, New York, United States of America.
Syed M ShahInstitute of Public Health, College of Medicine and Health Sciences, UAE University, Al-Ain, United Arab Emirates.
Tom LoneyCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.ORCID https://orcid.org/0000-0003-1687-6587
Wael AlmahmeedHeart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Youssef IdaghdourPublic Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Luai A AhmedInstitute of Public Health, College of Medicine and Health Sciences, UAE University, Al-Ain, United Arab Emirates.
Raghib AliPublic Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFamily history of cardiovascular disease (CVD) is an independent risk factor for coronary heart disease, and the risk increases with number of family members affected. It offers insights into shared genetic, environmental and lifestyle factors that influence heart disease risk. In this study, we aimed to estimate the association of family history of CVD and its risk factors, as well as the number of affected parents or siblings, with the prevalence of major cardiometabolic risk factors (CRFs) such as hypertension, dysglycemia, dyslipidemia and obesity in a sample of young adults.

methodsThe study utilized a cross-sectional analysis of baseline data from the UAE Healthy Future Study (UAEHFS), involving 5,058 respondents below the age of 40 years. Information on parental and sibling health regarding heart disease and stroke, hypertension, type 2 diabetes (T2D), high cholesterol and obesity, was gathered through a self-completed questionnaire. CRFs were estimated based on body measurements, biochemical markers and self-reported conditions. Multivariate regression analyses were used to examine the associations between categories of family history and the estimated CRFs.

resultsMore than half (58%) of the sample reported having a positive family history of CVD or its risk factors. The most common family history reported was T2D and hypertension, which accounted for 39.8% and 35% of the sample, respectively. The prevalence of all CRFs was significantly higher among those with a positive family history compared to those without family-history (P < 0.001). The prevalence and likelihood of having a CRF increased as the number of parents and/or siblings affected increased, indicating a potential dose-response trend. The odds were highest among individuals with both parental-and-sibling family history of disease, where they increased to 2.36 (95% CI 1.68-3.32) for hypertension, 2.59 (95% CI 1.86-3.60) for dysglycemia, 1.9 (95% CI 1.29-2.91) for dyslipidemia and 3.79 (95% CI 2.83-5.06) for obesity.

conclusionIn this study, we addressed the effect of family history as an independent risk factor on the major CRFs for the first time in the region. We observed that the majority of young Emirati adults had a positive family history of CVD-related diseases. Family history showed a strong association with the increased prevalence of CRFs. Additionally, having more relatives with specific diseases was associated with a higher risk of developing CRFs. Identifying people with a history of these conditions can help in early intervention and personalized risk assessments.

Indexed as

Cardiometabolic Risk FactorsCardiovascular DiseasesAdultCross-Sectional StudiesFemaleHumansMaleMedical History TakingObesityPrevalenceRisk FactorsUnited Arab EmiratesYoung Adult

Identifiers

PMID40073342
PMCPMC11903036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.